Five-year Follow-up of a Phase II Study of DA-EPOCH-R with High-dose MTX in CD5-positive DLBCL
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Rectum necrosis in a patient with severe COVID19 infection after CAR-T therapy: a case report.
Saeki K, Nakagama H, Tanaka Y, Goto Y, Kaneshiro K, Kono H Surg Case Rep. 2024; 10(1):227.
PMID: 39325308 PMC: 11427651. DOI: 10.1186/s40792-024-02026-1.
References
1.
Yamaguchi M, Nakamura N, Suzuki R, Kagami Y, Okamoto M, Ichinohasama R
. De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients. Haematologica. 2008; 93(8):1195-202.
DOI: 10.3324/haematol.12810.
View
2.
Miyazaki K, Yamaguchi M, Suzuki R, Kobayashi Y, Maeshima A, Niitsu N
. CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab. Ann Oncol. 2011; 22(7):1601-1607.
DOI: 10.1093/annonc/mdq627.
View
3.
Miyazaki K, Asano N, Yamada T, Miyawaki K, Sakai R, Igarashi T
. DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study. Haematologica. 2020; 105(9):2308-2315.
PMC: 7556618.
DOI: 10.3324/haematol.2019.231076.
View